Phosphaturic Mesenchymal Tumors: Rethinking the Clinical Diagnosis and Surgical Treatment

被引:5
|
作者
Liu, Yupeng [1 ,2 ]
He, Hongbo [1 ,2 ]
Zhang, Can [1 ,2 ]
Zeng, Hao [1 ]
Tong, Xiaopeng [1 ]
Liu, Qing [1 ,2 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Orthopaed, 87th Xiangya Rd, Changsha 410008, Peoples R China
[2] Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha 410008, Peoples R China
基金
中国博士后科学基金;
关键词
phosphaturic mesenchymal tumors; tumor-induced osteomalacia; hypophosphataemia; FGF-23; Tc99m-octreotide PET; CT; OSTEOMALACIA;
D O I
10.3390/jcm12010252
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The diagnosis of phosphaturic mesenchymal tumors (PMT) is easily delayed clinically, and their surgical treatment is unstandardized. This study aimed to evaluate our experience in the diagnosis and treatment of PMT and provide a research basis for the accurate and standardized treatment of PMT. Materials and Methods: Twelve patients diagnosed with PMT in our department and who underwent surgical treatment were included in this study. Preoperative demographic and clinical information were recorded. CT, MRI, and technetium-99m (Tc99m)-octreotide PET/CT imaging techniques were used to evaluate the general conditions and lesion boundaries of the tumors. Surgical treatment was performed using radical resection and microwave ablation-assisted extended curettage according to the lesion location and size. Patients were strictly followed up with and evaluated for oncological prognosis, radiological results, bone healing, serum ion levels, limb function, and pain level; the occurrence of complications was also recorded. Results: Three patients underwent radical resection, and nine underwent microwave ablation-assisted extended curettage. The average duration of symptoms in this group was 1.5 years (9-35 months) before diagnosis. Serum phosphate and AKP levels returned to normal one and two weeks postoperatively, respectively. There was no apparent specificity in the pathological findings; however, the immunohistochemistry of FGF-23 was positive, and the original fracture sites were effectively healed during the follow-up. The limb function and pain scores were significantly improved. The MSTS score increased from 15.3 to 29.0, and the VAS score decreased from 5.3 to 0.4. All patients recovered, and 90% resumed their original jobs. Conclusions: Accurate diagnosis and standardized surgical treatment are crucial to achieving a clinical cure for PMT. Combining clinical manifestations, biochemical examinations, imaging characteristics, and pathological findings is an effective way to diagnose PMT accurately. Radical resection and microwave ablation-assisted extended curettage are reliable surgical treatment methods for PMT.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Surgical Treatment and Outcomes for Sinonasal and Skull Base Phosphaturic Mesenchymal Tumors
    Tang, Ru
    Mao, Song
    Lin, Hai
    Ye, Hai-Bo
    Li, Da-Wei
    Chen, Zheng-Nong
    Su, Kai-Ming
    Zhang, Wei-Tian
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2020, 162 (05) : 674 - 682
  • [2] Clinical and imaging features of phosphaturic mesenchymal tumors
    Chang Cheng
    Yu Aihong
    You Yuhua
    Peng Xiaoxin
    Cheng Xiaoguang
    Li Xintong
    Liang Wei
    Gong Lihua
    Deng Wei
    中华医学杂志英文版, 2023, 136 (03)
  • [3] Clinical and imaging features of phosphaturic mesenchymal tumors
    Chang, Cheng
    Yu, Aihong
    You, Yuhua
    Peng, Xiaoxin
    Cheng, Xiaoguang
    Li, Xintong
    Liang, Wei
    Gong, Lihua
    Deng, Wei
    CHINESE MEDICAL JOURNAL, 2023, 136 (03) : 351 - 353
  • [4] Intracranial Phosphaturic Mesenchymal Tumors
    Raisanen, Jack
    Hatanpaa, Kimmo
    Beshay, Joseph
    Herndon, Emily
    Hladik, Christa
    Mickey, Bruce
    Burns, Dennis
    White, Charles
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2009, 68 (05): : 586 - 587
  • [5] Diagnosis: Phosphaturic mesenchymal tumor
    Yashar, Hila
    Flaman, Ashley
    Frost, Adam
    Caragea, Mara
    Thejeel, Bashiar
    SKELETAL RADIOLOGY, 2025,
  • [6] Imaging characteristics of phosphaturic mesenchymal tumors
    Gupta, Amit
    Kandasamy, Devasenathipathy
    Sharma, Raju
    Damle, Nishikant
    Goyal, Ankur
    Goyal, Alpesh
    Agarwal, Shipra
    Dharmashaktu, Yamini
    ACTA RADIOLOGICA, 2023, 64 (06) : 2061 - 2073
  • [7] Unusual Presentation and Surgical Treatment of a Phosphaturic Mesenchymal Tumor in a Knee
    Sun, Juan
    Zhou, Xi
    Xia, Weibo
    Wu, Huanwen
    Liu, Shuzhong
    Wang, Huizhen
    Liu, Yong
    FRONTIERS IN SURGERY, 2022, 9
  • [8] Imaging features of phosphaturic mesenchymal tumors
    Stephen M. Broski
    Andrew L. Folpe
    Doris E. Wenger
    Skeletal Radiology, 2019, 48 : 119 - 127
  • [9] Phosphaturic mesenchymal tumors: A review and update
    Folpe, Andrew L.
    SEMINARS IN DIAGNOSTIC PATHOLOGY, 2019, 36 (04) : 260 - 268
  • [10] Clinical, histopathologic, subtype, and immunohistochemical analysis of jaw phosphaturic mesenchymal tumors
    Li, Dongmei
    Zhu, Ran
    Zhou, Lian
    Zhong, Dingrong
    MEDICINE, 2020, 99 (07)